Your browser doesn't support javascript.
loading
Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer.
Leary, Alexandra; Genestie, Catherine; Blanc-Durand, Félix; Gouy, Sébastien; Dunant, Ariane; Maulard, Amandine; Drusch, Françoise; Cheaib, Bianca; Michels, Judith; Bentivegna, Enrica; LeFormal, Audrey; Mesnage, Soizick; Morice, Philippe; Pautier, Patricia; Khairallah, Aya S.
Afiliación
  • Leary A; Gynecological Cancer Unit, Department of Medicine, Institut Gustave Roussy, Villejuif, France. Alexandra.leary@gustaveroussy.fr.
  • Genestie C; Medical Oncologist, Gynecology Unit, INSERM U981, Institut Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France. Alexandra.leary@gustaveroussy.fr.
  • Blanc-Durand F; Pathology Department, Institut Gustave Roussy, Villejuif, France.
  • Gouy S; Gynecological Cancer Unit, Department of Medicine, Institut Gustave Roussy, Villejuif, France.
  • Dunant A; Gynecological Cancer Unit, Department of Medicine, Institut Gustave Roussy, Villejuif, France.
  • Maulard A; Biostatistics and Epidemiology Unit, Institut Gustave Roussy, Villejuif, France.
  • Drusch F; Gynecological Cancer Unit, Department of Medicine, Institut Gustave Roussy, Villejuif, France.
  • Cheaib B; Pathology Department, Institut Gustave Roussy, Villejuif, France.
  • Michels J; Department of Cancer Medicine, Breast Cancer Committee, Institut Gustave Roussy, Villejuif, France.
  • Bentivegna E; Gynecological Cancer Unit, Department of Medicine, Institut Gustave Roussy, Villejuif, France.
  • LeFormal A; Gynecological Cancer Unit, Department of Medicine, Institut Gustave Roussy, Villejuif, France.
  • Mesnage S; INSERM U981, Institut Gustave Roussy, Villejuif, France.
  • Morice P; INSERM U981, Institut Gustave Roussy, Villejuif, France.
  • Pautier P; Gynecological Cancer Unit, Department of Medicine, Institut Gustave Roussy, Villejuif, France.
  • Khairallah AS; Gynecological Cancer Unit, Department of Medicine, Institut Gustave Roussy, Villejuif, France.
Cancer Immunol Immunother ; 70(2): 519-531, 2021 Feb.
Article en En | MEDLINE | ID: mdl-32852603
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Terapia Neoadyuvante / Carcinoma Epitelial de Ovario Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Terapia Neoadyuvante / Carcinoma Epitelial de Ovario Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2021 Tipo del documento: Article